Phathom (PHAT) analyst forecast and price target
Analyst forecast
Consensus of 10 analyst ratings
Based on 5 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Leerink Partners | Initiated Coverage | Market Perform | $10.00 | Sep 9, 2026 |
| Barclays | Maintained | Overweight | $14.00 from $18.00 | Aug 17, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 | Jul 31, 2026 |
| Guggenheim | Maintained | Buy | $22.00 from $25.00 | Jul 31, 2026 |
| Needham | Maintained | Buy | $22.00 from $28.00 | Jul 30, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 | Jun 17, 2026 |
| Barclays | Upgraded | Equal-Weight → Overweight | $18.00 from $16.00 | Mar 27, 2026 |
| Guggenheim | Maintained | Buy | $25.00 from $20.00 | Feb 27, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $16.00 | Dec 9, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 from $20.00 | Oct 31, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 | Jun 9, 2025 |
| Craig-Hallum | Maintained | Buy | $17.00 from $12.00 | Jun 9, 2025 |
| Needham | Maintained | Buy | $28.00 | Jun 6, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $20.00 from $28.00 | May 2, 2025 |
| Guggenheim | Maintained | Buy | $12.00 from $18.00 | May 2, 2025 |
| Goldman Sachs | Maintained | Neutral | $5.00 from $10.00 | May 2, 2025 |
| Needham | Maintained | Buy | $28.00 | Apr 21, 2025 |
| Goldman Sachs | Maintained | Neutral | $10.00 from $12.00 | Apr 17, 2025 |
| Needham | Maintained | Buy | $28.00 | Apr 9, 2025 |
| Needham | Maintained | Buy | $28.00 | Apr 2, 2025 |
Frequently asked questions
What is the price target for PHAT stock?
The average 12-month analyst price target for Phathom (PHAT) is $18.80, with a high estimate of $26.00 and a low of $10.00, across 5 analysts.
Is PHAT a buy, sell, or hold?
Analysts covering Phathom currently average a Buy rating: 9 buy, 1 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for PHAT?
The average price target of $18.80 implies 150.67% upside from the last price of $7.50.
What is the latest analyst rating on PHAT?
On Sep 9, 2026, Leerink Partners initiated coverage of Phathom at Market Perform with a price target of $10.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.